LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.58 | 84.90 | 62 | 663 | 0.0935 | -0.1005 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.58 | 84.90 | 1058 | 663 | 1.5948 | 1.3408 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.29 | 84.90 | 7 | 766 | 0.0091 | -0.5443 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.29 | 84.90 | 1020 | 766 | 1.3301 | 1.1880 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.29 | 84.90 | 110 | 766 | 0.1434 | 0.0850 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.29 | 84.90 | 1056 | 766 | 1.3770 | 1.2120 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.99 | 84.90 | 9 | 898 | 0.0100 | -0.4827 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.99 | 84.90 | 974 | 898 | 1.0835 | 1.0476 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.99 | 84.90 | 163 | 898 | 0.1813 | 0.2112 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.99 | 84.90 | 1148 | 898 | 1.2770 | 1.1489 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 19.69 | 84.90 | 15 | 1239 | 0.0121 | -0.3612 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 19.69 | 84.90 | 1059 | 1239 | 0.8544 | 0.9203 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 19.69 | 84.90 | 484 | 1239 | 0.3905 | 0.5684 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 19.69 | 84.90 | 1123 | 1239 | 0.9061 | 0.9496 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.40 | 84.90 | 19 | 1454 | 0.0131 | -0.3060 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.40 | 84.90 | 999 | 1454 | 0.6868 | 0.8248 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.40 | 84.90 | 729 | 1454 | 0.5012 | 0.6898 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.40 | 84.90 | 1104 | 1454 | 0.7589 | 0.8698 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 23.10 | 84.90 | 14 | 1616 | 0.0087 | -0.3456 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 23.10 | 84.90 | 1066 | 1616 | 0.6596 | 0.8135 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 23.10 | 84.90 | 829 | 1616 | 0.5129 | 0.7093 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 23.10 | 84.90 | 1104 | 1616 | 0.6831 | 0.8285 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.81 | 84.90 | 19 | 1769 | 0.0107 | -0.2894 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.81 | 84.90 | 1132 | 1769 | 0.6397 | 0.8061 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.81 | 84.90 | 801 | 1769 | 0.4527 | 0.6691 | MN20160318_Q02 | K04 |